K. O'Reilly

发表

Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosis

Mark G. Jones, A. Nicholson, D. Hansell, 2016, JCI insight.

Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis.

A. Ganesan, D. Davies, K. O'Reilly, 2012, American journal of respiratory cell and molecular biology.

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study

Jordan J. Clark, Michael J. Murphy, Megan L. Nagel, 2020, American journal of respiratory and critical care medicine.

The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluation

A. Wells, K. O'Reilly, J. Colquitt, 2014, BMC Pharmacology and Toxicology.

30 – Gender-Specific Considerations in Interstitial Lung Disease

K. O'Reilly, P. Sime, L. Daugherty, 2004 .

Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer.

K. O'Reilly, P. Sime, C. Baglole, 2004, American journal of physiology. Lung cellular and molecular physiology.

Idiopathic inflammatory myositis-associated interstitial lung disease: ethnicity differences and lung function trends in a British cohort.

K. O'Reilly, F. Chua, C. Edwards, 2012, Rheumatology.

COVID-19 induces a hyperactive phenotype in circulating platelets

K. O'Reilly, N. Moran, B. Kevane, 2020, medRxiv.

Crystalline and amorphous silica differentially regulate the cyclooxygenase-prostaglandin pathway in pulmonary fibroblasts: implications for pulmonary fibrosis.

K. O'Reilly, T. Thatcher, P. Sime, 2005, American journal of physiology. Lung cellular and molecular physiology.

A disintegrin and metalloprotease (ADAM) 33 protein in patients with pulmonary sarcoidosis

Mark G. Jones, P. Howarth, D. Davies, 2012, Respirology.

Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia.

S. Birring, K. Dimopoulos, P. Corris, 2014, American journal of respiratory and critical care medicine.

Choice of Methodology Impacts Outcome in Indirect Comparisons of Drugs for Idiopathic Pulmonary Fibrosis

K. O'Reilly, J. Colquitt, E. Loveman, 2019, Medicina.

Outcome of hospitalisation for COVID-19 in patients with Interstitial Lung Disease: An international multicentre study.

Mark G. Jones, Reilly, M. Kreuter, 2020, medRxiv.

A qualitative exploration of people living with idiopathic pulmonary fibrosis experience of a virtual pulmonary rehabilitation programme

K. O'Reilly, Orlagh O'Shea, G. Murphy, 2022, BMC Pulmonary Medicine.

M. Schuhmann, K. O'Reilly, F. Brims, 2011, American family physician.

Phenotypes of organ involvement in sarcoidosis

J. Milanowski, A. Günther, M. Krawczak, 2018, European Respiratory Journal.

Dyspnoea, rhinorrhoea and pulmonary infiltrates in a healthy young woman

Mark G. Jones, K. Leslie, K. O'Reilly, 2013, Thorax.

Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment.

K. O'Reilly, P. Sime, 2001, Clinical immunology.

Routine Hematological Parameters May Be Predictors of COVID-19 Severity

K. O'Reilly, B. Kevane, F. Ní Áinle, 2021, Frontiers in Medicine.

Asbestos-related Lung Disease

William S. Beckett, W. Beckett, K. O'Reilly, 2007 .

The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluation.

A. Wells, K. O'Reilly, J. Colquitt, 2015, Health technology assessment.

The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis

Mark G. Jones, A. Ganesan, P. Skipp, 2017, Oncotarget.

Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis

Mark G. Jones, D. Davies, P. Thurner, 2018, eLife.

Persistent culture-positive Legionella infection in an immunocompromised host.

R. Betts, K. O'Reilly, M. Urban, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants.

Jong Sun Park, E. Silverman, H. Collard, 2023, American journal of respiratory and critical care medicine.

European consensus statement on the terminology used in the management of lupus glomerulonephritis

Kenneth G. C. Smith, C. Gordon, D. Adu, 2009, Lupus.

Perspectives of Interstitial Lung Disease Patients and Carers During COVID-19.

K. O'Reilly, L. Galvin, G. O'Dowd, 2021, Irish medical journal.

Comparing new treatments for idiopathic pulmonary fibrosis – a network meta-analysis

K. O'Reilly, J. Colquitt, E. Loveman, 2015, BMC Pulmonary Medicine.

Time taken from primary care referral to a specialist centre diagnosis of idiopathic pulmonary fibrosis: an opportunity to improve patient outcomes?

Mark G. Jones, L. Richeldi, K. O'Reilly, 2020, ERJ Open Research.

M. Schuhmann, K. O'Reilly, F. Brims, 2011 .

Phenotypes of organ involvement in sarcoidosis

J. Milanowski, A. Günther, M. Krawczak, 2018, European Respiratory Journal.

Ambulatory monitoring of patients with COVID-19: initial experiences and next steps

K. O'Reilly, G. Sheehan, M. Creed, 2022, BMJ Innovations.